Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03750409Not ApplicableActive Not Recruiting

Assessing Feasibility of Prolonged Repetitive Near Infrared Light Stimulation in Early to Mid-Stage Dementia

Role: collaborator

NCT01059877Not ApplicableCompleted

Efficacy of 1072nm Infrared Stimulation on Executive Functioning in Dementia

Role: lead

NCT01168466Not ApplicableCompleted

EEG Biofeedback to Improve Memory in Adults With Dementia

Role: lead

All 3 trials loaded